2011 - TID Conference
4.2 - Carbapenemases and Organ Transplantation
Presenter: Costi D., Sifri, Charlottesville, USA
Authors: Costi D. Sifri, Charlottesville, VA, USA
4.2 ‑Carbapenemases and Organ Transplantation
Costi D. Sifri, Charlottesville, VA, USA
Carbapenem resistant Enterobacteriaceae (CRE) have recently emerged as challenging hospital-associated pathogens worldwide, and solid organ transplant recipients may be at particularly high risk for infection by these problematic multidrug resistant pathogens. This session will review the evolving epidemiology of CRE in transplantation, describe risk factors for infection, and discuss possible treatment and prevention strategies for CRE infection following transplantation and their limitations.
You must be logged in to view recordings
By viewing the material on this site you understand and accept that:
- The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
- The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
- The material is solely for educational purposes for qualified health care professionals.
- The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
- The information cannot be used as a substitute for professional care.
- The information does not represent a standard of care.
- No physician-patient relationship is being established.